Pregnancy, Daily Care, and Prevention Strategies
At a Glance
During pregnancy, vulvovaginal candidiasis is generally treated with a 7-day vaginal antifungal cream such as miconazole or clotrimazole. Oral fluconazole, ibrexafungerp, and boric acid are avoided; gentle external care and no douching can reduce irritation.
Managing yeast infections involves more than just treating the active symptoms; it requires a thoughtful approach to daily habits and, during pregnancy, a heightened focus on safety. Understanding what the evidence says about prevention can help you make informed choices about your long-term health.
Yeast Infections and Pregnancy
If you are pregnant, you are at an increased risk for vulvovaginal candidiasis (VVC). Prevalence estimates suggest that about 20% of pregnant women develop VVC, with that number rising to 30% in the third trimester [1][2].
During pregnancy, the choice of treatment is strictly guided by fetal safety:
- Preferred Treatment: A 7-day course of topical vaginal cream (such as miconazole or clotrimazole) is the standard of care [2][3]. This approach effectively treats the infection while minimizing the amount of medication that enters your bloodstream [2].
- Medications to Avoid: Oral medications like fluconazole (even single doses) are generally avoided during pregnancy due to potential links to miscarriage and certain birth defects, such as heart or craniofacial malformations [3][2]. Newer oral drugs like ibrexafungerp and traditional treatments like boric acid are also strictly avoided because of risks to the developing fetus [4][5].
Daily Vulvar Care and Hygiene
While many hygiene products are marketed for “feminine health,” research suggests that less is often more when it comes to preventing yeast overgrowth and reducing irritation.
- Avoid Douching and Washes: Frequent intravaginal douching has been strongly associated with an increased risk of VVC [6]. Similarly, using “feminine washes” or vaginal soaps is linked to a higher risk of recurrent infections [7]. These products can disrupt the natural pH and healthy bacteria that keep yeast in check. Wash the external vulva gently with water or a fragrance-free cleanser, and avoid scrubbing.
- Clothing Choices: Observational studies have found that frequently wearing tight clothing or non-breathable synthetic fabrics (like tights or certain types of underwear) may increase VVC risk [6][8]. Choosing breathable cotton underwear and changing out of damp clothing (like a wet swimsuit) are often recommended as optional comfort measures to reduce physical irritation, though they are not proven to prevent infections on their own.
The Role of Probiotics
Many patients turn to probiotics to “restore balance,” but the medical evidence for their effectiveness in VVC is mixed.
- As an “Add-on” Therapy: Some studies suggest that taking specific probiotics alongside antifungal medication may slightly improve short-term cure rates [9][10].
- Not a Standalone Cure: Probiotics are considered a helper (adjuvant) therapy, not a replacement for standard antifungals [9]. Current clinical guidelines do not yet recommend them as a standard treatment because long-term evidence that they prevent future infections is weak and inconsistent [3][11].
Partners and Prevention Myths
There are several common misconceptions about how to prevent yeast infections from returning.
- Sexual Partners: Routine treatment of a sexual partner who has no symptoms is not recommended for VVC, because yeast is not usually acquired from a partner [12]. Research has not shown that treating an asymptomatic partner prevents you from getting another infection [13]. (Note: If a different infection like trichomoniasis is found, treatment of all current sex partners is required).
- Dietary Sugar: While reducing sugar is a frequent piece of advice, there are no large clinical trials proving that a “yeast-free diet” prevents infections [6]. It is more important to focus on evidence-based steps, such as managing diagnosed conditions like diabetes, since uncontrolled blood sugar is a known risk factor.
- Antibiotic Use: Using antibiotics is a well-documented trigger for yeast overgrowth [14]. If you have a history of recurrent yeast infections, it is important to tell your doctor before starting any antibiotic course so they can monitor you or provide preventive options if necessary [15].
By focusing on gentle vulvar care, avoiding unnecessary internal washes, and choosing safe treatments during pregnancy, you can better manage your vaginal health and reduce the frequency of uncomfortable episodes.
Common questions in this guide
What is the safest way to treat vulvovaginal candidiasis during pregnancy?
Can douching or feminine washes lead to recurring yeast infections?
Do probiotics cure or prevent vaginal yeast infections?
Can antibiotics trigger a vaginal yeast infection?
Does my partner need treatment if they have no yeast infection symptoms?
Can reducing sugar prevent vaginal yeast infections?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Daily vulvar care
Which everyday hygiene habits could help reduce yeast overgrowth?
Role of probiotics
Would probiotics alongside antifungal medication be worth discussing with my doctor?
Antibiotic use
Could antibiotics raise my risk of yeast overgrowth?
Get notified when new evidence is published on vulvovaginal candidiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Candidiasis in Pregnancy: Relevant Aspects of the Pathology for the Mother and the Fetus and Therapeutic Strategies.
Messina A, Mariani A, Brandolisio R, et al.
Tropical medicine and infectious disease 2024; (9(5)) doi:10.3390/tropicalmed9050114.
PMID: 38787047 - 2
Vulvovaginal candidiasis in pregnancy.
Aguin TJ, Sobel JD
Current infectious disease reports 2015; (17(6)):462 doi:10.1007/s11908-015-0462-0.
PMID: 25916994 - 3
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Nyirjesy P, Brookhart C, Lazenby G, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(Suppl_2)):S162-S168 doi:10.1093/cid/ciab1057.
PMID: 35416967 - 4
Ibrexafungerp: A new triterpenoid antifungal.
Sucher AJ, Thai A, Tran C, et al.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2022; (79(24)):2208-2221 doi:10.1093/ajhp/zxac256.
PMID: 36083109 - 5
Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus.
Phillips NA, Bachmann G, Haefner H, et al.
Women's health reports (New Rochelle, N.Y.) 2022; (3(1)):38-42 doi:10.1089/whr.2021.0065.
PMID: 35136875 - 6
Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi'an: A Cross-Sectional Study.
Zeng X, Zhang Y, Zhang T, et al.
BioMed research international 2018; (2018()):9703754 doi:10.1155/2018/9703754.
PMID: 29977925 - 7
Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women.
Otoo-Annan E, Senoo-Dogbey VE
BMC public health 2024; (24(1)):100 doi:10.1186/s12889-024-17668-x.
PMID: 38183091 - 8
Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
Fernandes Â, Azevedo N, Valente A, et al.
Medical mycology 2022; (60(5)) doi:10.1093/mmy/myac029.
PMID: 35482711 - 9
Probiotics for the treatment of vulvovaginal candidiasis in nonpregnant women: a systematic review and meta-analysis of randomized controlled trials.
Chen R, Qing W, Xu N, et al.
American journal of obstetrics and gynecology 2026; (234(6)):1604-1622 doi:10.1016/j.ajog.2026.01.009.
PMID: 41547378 - 10
Probiotics for vulvovaginal candidiasis in non-pregnant women.
Xie HY, Feng D, Wei DM, et al.
The Cochrane database of systematic reviews 2017; (11()):CD010496 doi:10.1002/14651858.CD010496.pub2.
PMID: 29168557 - 11
Epidemiology, Diagnostics and Therapy of Vulvovaginal Fungal Infections.
Frej-Mądrzak M, Jama-Kmiecik A, Górzyńska A, et al.
Pathogens (Basel, Switzerland) 2026; (15(9)) doi:10.3390/pathogens15090914.
PMID: 42796682 - 12
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, et al.
Mycoses 2021; (64(6)):583-602 doi:10.1111/myc.13248.
PMID: 33529414 - 13
The management of vulvovaginal candidiasis: the results of survey in Lviv, Ukraine.
Horodnycha O, Ryvak T, Nepyivoda O
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 2025; (74(2)):1-6 doi:10.36290/csf.2025.022.
PMID: 41412769 - 14
Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.
Shukla A, Sobel JD
Current infectious disease reports 2019; (21(11)):44 doi:10.1007/s11908-019-0700-y.
PMID: 31707496 - 15
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).
Palacios S, Espadaler J, Fernández-Moya JM, et al.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016; (35(10)):1701-8 doi:10.1007/s10096-016-2715-8.
PMID: 27393491
This page is for informational purposes only and does not constitute medical advice. During pregnancy or with recurrent symptoms, consult your obstetrician or another healthcare professional for individualized treatment guidance.